Novamind to conduct phase 2 trial of psilocybin for depression

Stock Information for Novamind Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Novamind Inc.

Novamind Obtains Final Order for Plan of Arrangement from the Supreme Court of British Columbia and Completes Acquisition by Numinus Wellness Inc.
Novamind Shareholders Approve Proposed Acquisition by Numinus
Novamind Announces New Patient Financing Options
Novamind Reports Fiscal Q3 2022 Financial Results and Operating Highlights
Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Shareholders of Novamind Vote FOR the Proposed Plan of Arrangement
Novamind Launches Group Psychedelic Treatment for Frontline Workers
Novamind Files Management Information Circular for Special Meeting of Shareholders and Announces Receipt of Interim Court Order for Plan of Arrangement
Novamind to Host Bionomics' PREVAIL Trial for Acute Treatment of Social Anxiety Disorder

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.